Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 29, 2026 10:26 ET | Source: Research and Markets

Precision Medicine in Oncology Collaboration and Licensing Agreements Trends Report 2025 with Directory of 879 Deals - Upfront, Milestone, Royalties Terms, Company A-Z, Deal Type and Therapy Area

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a...
January 26, 2026 05:00 ET | Source: NUCLIDIUM AG

NUCLIDIUM Announces Issuance of New U.S. Patent Covering its 61Cu-based Radiodiagnostic Program for PSMA-positive Prostate Cancer

Patent for composition of matter and methods of use of high-radiopure diagnostic ⁶¹Cu-NU101 and combination use with therapeutic pair ⁶⁷Cu-NU101
January 23, 2026 08:11 ET | Source: Research and Markets

DNA Methylation Detection Technology Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "DNA Methylation Detection Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
January 21, 2026 08:30 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit

Grand Cayman, Cayman Island, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced...
January 21, 2026 04:52 ET | Source: Research and Markets

U.S. Bispecific Antibodies Forecast Report 2025-2033: Market to Grow by Over $260 Billion, Driven by Increased Cancer and Autoimmune Diseases, FDA Approvals, and Strategic Partnerships

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "U.S. Bispecific Antibodies Market Forecast to 2033" report has been added to ResearchAndMarkets.com's offering.The U.S. bispecific antibodies market...
January 21, 2026 04:14 ET | Source: Research and Markets

Molecular Cytogenetics Market Projecting Strong Growth, Hitting USD 5.41 Billion by 2031

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Molecular Cytogenetics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ...
January 06, 2026 07:30 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Releases CEO Letter to Shareholders Highlighting 2025’s Significant Achievements and Outlining Upcoming Milestones for 2026

SIL204 Demonstrated Significant Tumor Inhibition in Positive Pre Clinical Studies with Activity Across Pancreatic, Colorectal, and Lung Cancer Models Company’s Platform Seeks to Address an Estimated...
January 05, 2026 10:37 ET | Source: Research and Markets

Precision Medicine Collaboration and Licensing Agreements Analysis Report 2025 with Directory of 1,221 Deals Signed Since 2019 by Company A-Z, Deal Type and Therapy Area

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Precision Medicine Collaboration and Licensing Deals 2019-2025" report has been added to ResearchAndMarkets.com's offering. This report contains a...
December 16, 2025 08:40 ET | Source: Silexion Therapeutics Corp

Silexion Therapeutics Announces Submission of Phase 2/3 Clinical Trial Application to Israel for SIL204 in Locally Advanced Pancreatic Cancer

Regulatory submission marks a significant milestone as the Company advances toward Phase 2/3 trial initiation in Q2 2026 at full speed Application follows recent successful toxicology studies,...
December 10, 2025 10:00 ET | Source: 4D Path

4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology

4D Path has announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials.